Mohs Surgery: The Complete Patient Guide

Mohs Surgery Overview

Mohs micrographic surgery is a precise surgical technique for skin cancer removal that maximizes tissue preservation while ensuring complete tumor removal. Developed by Frederic Mohs in 1930s, this technique combines surgical accuracy with histological verification, achieving cure rates of 95-99% for basal cell carcinoma (highest recurrence-free rates of any treatment) and 95-97% for squamous cell carcinoma. The procedure removes skin cancer layer-by-layer, examining each layer microscopically until all cancer is removed, minimizing removal of healthy tissue and maximizing preservation of facial structures and function.

Indications and Candidates

Primary Indications: Basal cell carcinoma and squamous cell carcinoma with high recurrence risk (large size >1cm, aggressive histology, recurrent lesion, ill-defined borders, location on face/ears/hands/genitals). Primary melanoma considered in selected cases (thin melanomas, specific locations). Ideal Candidates: Patients with non-melanoma skin cancers, particularly high-risk features, on face/ears/hands or other cosmetically/functionally sensitive areas. Relative contraindications include uncontrolled anticoagulation, significant medical comorbidities precluding extended procedure, or inability to cooperate/remain still during procedure.

Advantages vs Traditional Excision

Traditional excision relies on predetermined margins (typically 4-6mm) and histological examination of peripheral/deep margins only. Mohs examination includes 100% of peripheral margins through comprehensive histological mapping, identifying any residual cancer and requiring additional layer removal until clear. This approach reduces incomplete removal rates from 20-30% (traditional excision) to <5% (Mohs). Tissue preservation is significantly superior: Mohs removes only cancer-containing tissue, while traditional excision often removes large margins of healthy tissue unnecessarily. Result: smaller defects, superior cosmetic/functional outcomes, and highest cure rates of any treatment.

Procedure Details

Tissue is removed in thin layers (approximately 0.5mm). Each layer is marked with dyes at different locations to create tissue map. Histological sections prepared identifying cancer extent. If cancer present at any margin, that specific area is re-excised and examined. Process repeats until entire peripheral and deep margins are cancer-free. All removed tissue preserved; reconstruction performed only after complete tumor removal confirmed. Procedure requires specialized equipment and histological expertise; only fellowship-trained Mohs surgeons should perform procedure.

Procedure Timeline

Simple cases (small, well-defined) may complete in 1-2 hours. Complex cases (large, ill-defined, high-risk locations) may require 3-4 hours or occasionally multiple stages. Patients wait between stages (typically 30-45 minutes) while histological processing occurs. Advance notice of likely procedure duration provided; patients should plan accordingly. Reconstruction typically occurs same day following complete tumor removal; if complex reconstruction needed, may be staged.

Cure Rates and Outcomes

Basal cell carcinoma: 99% 5-year cure rate (vs 94-98% for traditional excision). Squamous cell carcinoma: 95-97% 5-year cure rate (vs 92-96% for traditional excision). Recurrent tumors: 94% 5-year cure rate despite higher inherent recurrence risk. Superior cure rates combined with tissue conservation make Mohs ideal for high-risk lesions, particularly on face where tissue preservation maximizes cosmetic/functional outcomes.

Reconstruction Options

Primary Closure: Direct closure of defect; suitable for small defects. Flaps: Local tissue adjacent to defect rotated or advanced to close defect; preserves tissue characteristics. Examples: rotation flips, advancement flaps, rhombic flaps. Grafts: Full-thickness or split-thickness skin harvested from donor site and placed on defect; used when flaps unavailable or defect too large. Healing by Secondary Intention: Allows natural epithelialization from wound edges; particularly suitable for concave areas (temples, inner canthus) where scarring naturally minimal.

Recovery and Aftercare

Post-operative instructions include wound care (keeping clean and moist), dressing changes (typically daily), activity restriction (no strenuous activity 1-2 weeks), and suture removal (7-10 days for facial locations). Pain typically minimal; acetaminophen usually sufficient. Swelling and bruising peak at 48-72 hours; ice application within first 24 hours reduces swelling. Return to work typically 3-5 days for desk work; 1-2 weeks for strenuous activity. Full healing requires 4-6 weeks; scar maturation continues up to 12 months.

Scar Management

Mohs frequently produces superior cosmetic results due to precise defect closure. However, scars remain part of healing. Initial scars (2-4 weeks) appear red and slightly raised; over 3-6 months, redness fades and scar flattens. Scar revision (dermabrasion, laser) may further improve appearance after 6-12 months if scar prominent. Silicone products, sunscreen use, and massage potentially help; evidence modest. Accepting realistic scar appearance crucial to satisfaction; patient counseling important.